{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:38:46Z","timestamp":1773149926764,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2464,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1111\/j.1469-0691.2008.01924.x","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T12:04:31Z","timestamp":1284379471000},"page":"26-34","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S2","title":["Future strategies for treating Staphylococcus aureus bloodstream infections"],"prefix":"10.1016","volume":"14","author":[{"given":"C.K.","family":"Naber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2008.01924.x_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00000658-200104000-00011","article-title":"Impact of bloodstream infection on outcomes among infected surgical inpatients","volume":"233","author":"Raymond","year":"2001","journal-title":"Ann Surg"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1378\/chest.123.5.1615","article-title":"Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival","volume":"123","author":"Valles","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10096-006-0238-4","article-title":"Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia","volume":"26","author":"Cuijpers","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases","volume":"162","author":"Jensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-0691.2005.01359.x","article-title":"Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre","volume":"12","author":"Kaech","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.diagmicrobio.2005.06.009","article-title":"Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital","volume":"53","author":"Liao","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib9","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S1516-31802000000500004","article-title":"Epidemiology of bloodstream infections at a cancer center","volume":"118","author":"Velasco","year":"2000","journal-title":"Sao Paulo Med J"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib11","first-page":"317","article-title":"Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection","volume":"40","author":"Kuo","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib12","first-page":"63","article-title":"Staphylococcus aureus bacteremia and endocarditis","volume":"33","author":"Chang","year":"2000","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib15","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989. National Nosocomial Infections Surveillance System","volume":"91","author":"Banerjee","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","author":"Benfield","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/labinvest.3700501","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton\u2013Valentine leukocidin","volume":"87","author":"Boyle-Vavra","year":"2007","journal-title":"Lab Invest"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10096-005-1345-3","article-title":"Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995\u20132001","volume":"24","author":"Lyytikainen","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of Staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib20","series-title":"European Antimicrobial Resistance Surveillance System Annual Report","year":"2005"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/dki266","article-title":"Surveillance and epidemiology of MRSA bacteraemia in the UK","volume":"56","author":"Johnson","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"vii","key":"10.1111\/j.1469-0691.2008.01924.x_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0733-8651(03)00030-4","article-title":"Fowler VG Jr. Staphylococcus aureus bacteremia and endocarditis","volume":"21","author":"Petti","year":"2003","journal-title":"Cardiol Clin"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.128.2.489","article-title":"Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients","volume":"128","author":"Safdar","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM200101043440102","article-title":"Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group","volume":"344","author":"von Eiff","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks","volume":"10","author":"Kluytmans","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/502523","article-title":"Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia","volume":"26","author":"Reed","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/JCM.42.2.825-828.2004","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton\u2013Valentine leukocidin or exfoliative toxin genes","volume":"42","author":"Liassine","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/qjmed\/91.1.41","article-title":"Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs","volume":"91","author":"Willcox","year":"1998","journal-title":"Q J Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijantimicag.2007.01.017","article-title":"German guidelines for the diagnosis and management of infective endocarditis","volume":"29","author":"Naber","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib31","first-page":"180","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"24","author":"Mermel","year":"2001","journal-title":"J Intraven Nurs"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ehj.2003.11.008","article-title":"Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology","volume":"25","author":"Horstkotte","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"Gemmell","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.01924.x_bib34","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1444-0903.2005.00977.x","article-title":"Diagnosis and management of Staphylococcus aureus bacteraemia","volume":"35","author":"Mitchell","year":"2005","journal-title":"Intern Med J"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib35","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1086\/374243","article-title":"Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive","volume":"36","author":"Paterson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diagmicrobio.2005.02.007","article-title":"Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia","volume":"52","author":"Lodise","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1086\/367653","article-title":"Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection","volume":"36","author":"Engemann","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.01924.x_bib39","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/491714","article-title":"The role of vancomycin in the treatment paradigm","volume":"42","author":"Stevens","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.01924.x_bib40","first-page":"ii37","article-title":"Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter","volume":"51","author":"Nathwani","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.01924.x_bib41","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkl373","article-title":"Antibiotic resistance\u2014action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12\u201313 December 2005","volume":"58","author":"Finch","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 3","key":"10.1111\/j.1469-0691.2008.01924.x_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1469-0691.2005.01141.x","article-title":"The need for new therapeutic agents: what is the pipeline","volume":"11","author":"Shah","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10096-006-0096-0","article-title":"Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia","volume":"25","author":"Khatib","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib44","first-page":"508","article-title":"PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids","volume":"9","author":"Yamamoto","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/JCM.43.1.163-167.2005","article-title":"PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis","volume":"43","author":"Rovery","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1198-743X.2004.00821.x","article-title":"Detection of bacterial DNA in cardiac vegetations by PCR after the completion of antimicrobial treatment for endocarditis","volume":"10","author":"Lang","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib47","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1128\/JCM.41.9.4435-4437.2003","article-title":"Streptococcus pneumoniae endocarditis: persistence of DNA on heart valve material 7 years after infectious episode","volume":"41","author":"Branger","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib48","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1469-0691.2006.01547.x","article-title":"Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay","volume":"12","author":"Holfelder","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/48.4.463","article-title":"The problem with cephalosporins","volume":"48","author":"Dancer","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1586\/14787210.4.3.357","article-title":"Role of linezolid in the treatment of complicated skin and soft tissue infections","volume":"4","author":"Peppard","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib51","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/AAC.47.5.1689-1693.2003","article-title":"Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000\u20132001","volume":"47","author":"Critchley","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 5","key":"10.1111\/j.1469-0691.2008.01924.x_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1120009X.2000.11782314","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"12","author":"Wood","year":"2000","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2006.05.009","article-title":"Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998\u20132004)","volume":"57","author":"Moet","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib54","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/JCM.36.4.1020-1027.1998","article-title":"Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides","volume":"36","author":"Tenover","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib55","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/AAC.47.4.1262-1266.2003","article-title":"Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis","volume":"47","author":"Moore","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib57","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib59","first-page":"902","article-title":"Vancomycin-resistant Staphylococcus aureus\u2014Pennsylvania, 2002","volume":"51","year":"2002","journal-title":"MMWR"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2008.01924.x_bib60","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib61","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib62","series-title":"Targocid 200 mg and 400 mg. Summary of product characteristics","year":"2006"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib63","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","article-title":"Linezolid: an oxazolidinone antimicrobial agent","volume":"23","author":"Fung","year":"2001","journal-title":"Clin Ther"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.01924.x_bib64","first-page":"ii45","article-title":"Safety and tolerability of linezolid","volume":"51","author":"French","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib65","series-title":"FDA Alert: linezolid","year":"2007"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib66","series-title":"Cubicin prescribing information","year":"2007"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib67","series-title":"Cubicin summary of product characteristics","year":"2007"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib68","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/AAC.00678-06","article-title":"Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates","volume":"50","author":"Wootton","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib69","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib70","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2006.10.007","article-title":"Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002\u20132005)","volume":"57","author":"Pfaller","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib71","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin\u2013dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib72","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1128\/AAC.48.12.4665-4672.2004","article-title":"Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model","volume":"48","author":"LaPlante","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib73","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/425009","article-title":"The importance of bactericidal drugs: future directions in infectious disease","volume":"39","author":"Finberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib74","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib75","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dki248","article-title":"Tigecycline","volume":"56","author":"Pankey","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib76","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1742-1241.2007.01318.x","article-title":"Dalbavancin: a novel antimicrobial","volume":"61","author":"Chen","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib77","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","article-title":"Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens","volume":"40","author":"Raad","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib78","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1586\/14787210.4.5.743","article-title":"Telavancin: a new lipoglycopeptide with multiple mechanisms of action","volume":"4","author":"Kanafani","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2008.01924.x_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2006.01404.x","article-title":"Ceftobiprole: in-vivo profile of a bactericidal cephalosporin","volume":"12","author":"Chambers","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diagmicrobio.2007.02.010","article-title":"In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection","volume":"58","author":"Rouse","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib81","series-title":"Tygacil summary of product characteristics","year":"2007"},{"key":"10.1111\/j.1469-0691.2008.01924.x_bib82","series-title":"Tygacil prescribing information","year":"2007"},{"issue":"suppl. 2","key":"10.1111\/j.1469-0691.2008.01924.x_bib83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2007.01725.x","article-title":"Clinical profile of ceftobiprole, a novel beta-lactam antibiotic","volume":"13","author":"Noel","year":"2007","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14609265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14609265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T11:13:27Z","timestamp":1591874007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14609265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":83,"alternative-id":["S1198743X14609265"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2008.01924.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}